Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. "We often see patients with chronic low back pain who ...
Stryker SYK recently received FDA clearance for its OptaBlate BVN Basivertebral Nerve Ablation System (OptaBlate BVN), a significant milestone in the treatment of chronic vertebrogenic lower back pain ...
Hosted on MSN
Stryker Receives FDA Clearance For OptaBlate System Aimed At Low Back Pain Relief: Retail’s Yet To React
Medical technology company Stryker Corp. (SYK) on Monday announced that its OptaBlate basivertebral nerve ablation system (BVNA) has received clearance from the U.S. Food and Drug Administration (FDA) ...
Stryker said Monday that its OptaBlate basivertebral nerve ablation system received 510(k) clearance from the Food and Drug Administration. The medical technology company said its OptaBlate BVNA is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results